BCM
PRPH

Bridgeway Capital Management’s ProPhase Labs PRPH Stock Holding History

Bridgeway Capital Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,310
Closed -$55.9K – 1278
2024
Q3 		$55.9K Buy
2,310
+14
+0.6% +$394 ﹤0.01% 1206
2024
Q2 		$96K Buy
2,296
+18
+0.8% +$943 ﹤0.01% 1167
2024
Q1 		$147K Buy
2,278
+17
+0.8% +$861 ﹤0.01% 1157
2023
Q4 		$102K Sell
2,261
-980
-30% -$44.7K ﹤0.01% 1238
2023
Q3 		$142K Buy
3,241
+15
+0.5% +$878 ﹤0.01% 1157
2023
Q2 		$234K Sell
3,226
-2,213
-41% -$180K 0.01% 1097
2023
Q1 		$414K Buy
5,439
+250
+5% +$20.2K 0.01% 928
2022
Q4 		$500K Hold
5,189
– – 0.01% 881
2022
Q3 		$585K Buy
5,189
+3,869
+293% +$450K 0.02% 856
2022
Q2 		$167K Buy
+1,320
New +$116K ﹤0.01% 1127

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bridgeway Capital Management's PRPH Position: Q4 2024 in Review

Bridgeway Capital Management sold out of ProPhase Labs (PRPH) in Q4 2024, closing a stake of 2,310 shares — an estimated $55.9K sold.

Bridgeway Capital Management first reported a position in PRPH in Q2 2022 and held it in 10 quarters. The position peaked at $585K in Q3 2022. 30 funds tracked by Wall St. Rank hold PRPH as of Q4 2024.

  • Bridgeway Capital Management reported no remaining ProPhase Labs position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,310 ProPhase Labs shares in Q4 2024, an estimated $55.9K.
  • Bridgeway Capital Management first reported a position in ProPhase Labs in Q2 2022 and held it in 10 quarters.
  • Bridgeway Capital Management's ProPhase Labs position peaked at $585K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.